| Accession |
PRJCA015062 |
| Title |
SHR0302-111-A single-center, open, single-arm, fixed-sequence SHR0302 tablet on the pharmacokinetic effects of CYP3A4, CYP2C8, CYP2C9, CYP2C19 pointer substrates in healthy subjects |
| Relevance |
Medical |
| Data types |
Clinical, impact, metabolic data, etc
|
| Organisms |
Homo sapiens
|
| Description |
SHR0302-111-A single-center, open, single-arm, fixed-sequence SHR0302 tablet on the pharmacokinetic effects of CYP3A4, CYP2C8, CYP2C9, CYP2C19 pointer substrates in healthy subjects |
| Sample scope |
Multiisolate |
| Release date |
2023-02-20 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
weiqing ge
weiqing
ge (weiqing.ge@hengrui.com)
|
| Organization |
Jiangsu Hengrui pharmaceutical Co.LTD |
| Submission date |
2023-02-20 |
